BioSpace News Archive

Business

2seventy bio Announces Upcoming Investor Events

2seventy bio announced today that it will host a series of investor events to share further detail on its research pipeline and strategy.

September 13, 2021
·
1 min read
Lone Star Bio

Apollo Endosurgery to Present at Lake Street’s 5th Annual Best Ideas Growth Conference

Apollo Endosurgery, Inc. today announced that its management team will participate in Lake Street’s 5th Annual Best Ideas Growth Conference. September 14-15, 2021

September 13, 2021
·
1 min read
Drug Development

ImmunityBio Announces Positive Durable Responses in BCG Unresponsive Bladder Cancer Patients with a Complete Response Rate of 72%, Median Duration of Complete Response of 19.9 Months, and 85% Remaining Cystectomy-free in Phase 2/3 Trial

ImmunityBio, Inc., a clinical-stage immunotherapy company, announced updated data from an ongoing bladder cancer trial showing sustained complete response rates in patients with BCG-unresponsive non-muscle invasive carcinoma in situ bladder cancer.

September 13, 2021
·
12 min read
Drug Development

Celldex Announces Initiation of CDX-0159 Subcutaneous Formulation Study

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first cohort has been dosed in the Phase 1 study of the subcutaneous formulation of CDX-0159 in healthy volunteers.

September 13, 2021
·
5 min read
Pharm Country

New Study Shows Most Blood Cancer Patients Benefit from an Additional COVID-19 Vaccine Dose

More than one in two patients with B-cell blood cancers produced antibodies to a third dose of COVID-19 vaccine despite having no detectable antibodies after the first two doses, according to a new study from The Leukemia & Lymphoma Society (LLS)

September 13, 2021
·
6 min read
Biotech Bay

Amgen To Showcase New Data From Inflammation Portfolio At EADV Virtual Congress 2021

Amgen (NASDAQ: AMGN) today announced that new data from its expanding inflammation pipeline and marketed portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 30th Congress, which will take place virtually Sept. 29 – Oct. 2.

September 13, 2021
·
23 min read
Business

EarlySign Announces New Partnership with Roche Diagnostics to Commercialize AI Solution for Early Detection of Cancer

Medial EarlySign (earlysign.com), a pioneering company developing AI-based clinical predictive analytics, announced today the signing of a definitive partnership agreement with Roche Diagnostics International Ltd.

September 13, 2021
·
2 min read
Business

Labcorp Selects Medidata’s Sensor Cloud to Expand Decentralized Clinical Trial Capabilities, Enabling First-in-Kind Industry Partnership for Digital Biomarker Discovery

Medidata, a Dassault Systèmes company, and Labcorp Drug Development, a global company providing clinical laboratory and end-to-end drug development services, today announced they have entered into an agreement using the Medidata Sensor Cloud.

September 13, 2021
·
5 min read
Business

Longeveron Partners with Kinesiometrics to Create and Implement Cutting-Edge Smart Phone App to Measure Physical Responses to Cell Therapy

Longeveron Inc. has entered into an agreement with Kinesiometrics Inc., (“Kinesiometrics”) to provide a cutting-edge, digital data-driven solution for objective real-time measurement of functional capacity and quality of life in Longeveron’s clinical studies.

September 13, 2021
·
6 min read
Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants Issued on June 4, 2020

The Company confirms that as of the close of markets on September 10, 2021, the Company is now in a position to exercise its Acceleration Right.

September 13, 2021
·
5 min read